Topics About
Topic: Gene Therapy and Biotechnology
A summary of mainstream reporting, plus the facts and perspectives it leaves out. A more honest account of each story.
📔 Topics / Gene Therapy and Biotechnology

Gene Therapy and Biotechnology

1 Story
4 Related Topics
FDA Approves First Dual-Vector Gene Therapy For OTOF-Related Congenital Deafness
Apr 24 Breaking 2
The FDA on April 23, 2026 approved the first dual-vector gene therapy for congenital deafness caused by OTOF mutations, authorizing Otarmeni (lunsotogene parvec-cwha) for pediatric and adult patients. Fox News

Related Topics

FDA & Drug Approvals FDA and Drug Approvals Hearing Loss and Deafness Medical Research & Gene Therapy